Jensen AD, Bergmann ZP, Garcia-Huttenlocher H, Freier K, Debus J, M ünter MW. Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience. Head Neck Oncol. 2010 Nov 26;2:34.

Conclusion RIT is a feasible treatment option for elderly and multi-morbid patients with promising therapeutic activity. Long-term disease control can also be achieved in patients receiving RIT for re-irradiation.
Source: Head and Neck Oncology - Category: Cancer & Oncology Source Type: research